{"id":8457,"date":"2025-11-28T13:20:17","date_gmt":"2025-11-28T13:20:17","guid":{"rendered":"https:\/\/blog.mygenericpharmacy.com\/?p=8457"},"modified":"2025-11-28T13:20:20","modified_gmt":"2025-11-28T13:20:20","slug":"new-pill-reduces-bad-cholesterol-levels-by-almost-60","status":"publish","type":"post","link":"https:\/\/blog.mygenericpharmacy.com\/index.php\/2025\/11\/28\/new-pill-reduces-bad-cholesterol-levels-by-almost-60\/","title":{"rendered":"New pill reduces ‘bad’ cholesterol levels by almost 60%"},"content":{"rendered":"\n

This is a significant and exciting development in the treatment of high cholesterol. Here\u2019s a detailed breakdown of what this news typically refers to, how it works, and its implications.<\/p>\n\n\n\n

The “New Pill” in Question<\/h3>\n\n\n\n

The drug you’re likely hearing about is a class of medications called siRNA (small interfering RNA) therapeutics<\/strong>. The most prominent one is Inclisiran<\/strong> (brand name Leqvio).<\/p>\n\n\n\n

While not brand-new to the market (it was approved in the EU in 2020 and the US in 2021), its real-world use and long-term data are still emerging, making it “new” in the public consciousness.<\/p>\n\n\n\n

How It Works: A Revolutionary Approach<\/h3>\n\n\n\n

Traditional statins and other pills work by blocking an enzyme in the liver that produces cholesterol. Inclisiran works differently, using a mechanism called RNA interference<\/strong>.<\/p>\n\n\n\n

    \n
  1. Target:<\/strong>\u00a0It focuses on a protein called\u00a0PCSK9<\/strong>. This protein normally destroys the receptors on your liver cells that remove “bad” LDL cholesterol from your blood. More PCSK9 means fewer receptors and higher LDL levels.<\/li>\n\n\n\n
  2. The “Interference”:<\/strong>\u00a0Inclisiran is not a daily pill. It’s a\u00a0twice-yearly subcutaneous injection<\/strong>\u00a0(a shot in the skin, like insulin). It contains a small piece of synthetic RNA that “interferes” with the genetic instructions in your liver cells for making the PCSK9 protein.<\/li>\n\n\n\n
  3. The Result:<\/strong>\u00a0By “silencing” the gene for PCSK9, the drug allows your liver to maintain more LDL receptors. These receptors can then effectively clear LDL cholesterol from your bloodstream, leading to reductions of around\u00a050%<\/strong>\u00a0on top of statin therapy, which aligns with the “almost 60%” figure.<\/li>\n<\/ol>\n\n\n\n

    Key Advantages<\/h3>\n\n\n\n
      \n
    1. Unprecedented Efficacy:<\/strong>\u00a0The ~60% reduction in LDL cholesterol is among the highest achieved by any single drug.<\/li>\n\n\n\n
    2. Remarkable Convenience:<\/strong>\u00a0The dosing schedule of\u00a0once initially, again at 3 months, and then every 6 months<\/strong>\u00a0is a game-changer. It eliminates the need for daily pills, which significantly improves adherence and long-term effectiveness.<\/li>\n\n\n\n
    3. Excellent Safety Profile:<\/strong>\u00a0So far, clinical trials have shown it to be very well-tolerated, with the most common side effects being mild reactions at the injection site.<\/li>\n<\/ol>\n\n\n\n

      Who Is It For?<\/h3>\n\n\n\n

      This is not a medication for everyone with slightly high cholesterol. It is typically prescribed for:<\/p>\n\n\n\n